Skip to main content

Advertisement

Log in

Metabolic factors and breast cancer risk in Korean women

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Metabolic factors have been suggested to be associated with breast cancer. However, the findings are inconsistent among studies. We conducted a case–control study in Korean women to evaluate the association between metabolic factors and premenopausal and postmenopausal breast cancer.

Methods

Incident breast cancer cases (270 women) and their controls (540 women) matched by age and menopausal status were recruited from the recipients of a health examination at the same institution. Five relevant factors of metabolic syndrome were evaluated. Odds ratios (OR) and 95 % confidence intervals (CI) for the association were estimated by conditional logistic regression analysis.

Results

Proportions of cases and controls with each factors were 25.6 and 20.6 % for obesity (body mass index ≥ 25 kg/m2), 17.4 and 17.4 % for high fasting glucose (≥5.55 mmol/L or use of hypoglycemic medication), 13.0 and 18.9 % for high triglyceride (≥1.69 mmol/L), 26.3 % and 23.9 % for low high-density lipoprotein cholesterol (<1.29 mmol/L), and 29.6 and 30.6 % for high blood pressure (≥130/or 85 mmHg or use of antihypertensive medication), respectively. Although only the obesity was associated with an increased risk of postmenopausal breast cancer (OR = 2.24; 95 % CI 1.22–4.10) among individual metabolic factors, women with aggregation of three or more metabolic factors as defined by international diabetes federation criteria showed greater risk for postmenopausal breast cancer compared with women without any factor (OR = 2.36; 95 % CI 1.10–5.10).

Conclusions

Although obesity was the only metabolic factor associated with postmenopausal breast cancer, the presence of other metabolic factors may further increase the risk of postmenopausal breast cancer when combined with obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

HDL-C:

High density lipoprotein cholesterol

References

  1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics. CA Cancer J Clin 55(1):10–30. doi:10.3322/canjclin.55.1.10

    Article  PubMed  Google Scholar 

  2. Toi M, Ohashi Y, Seow A, Moriya T, Tse G, Sasano H, Park BW, Chow LW, Laudico AV, Yip CH, Ueno E, Ishiguro H, Bando H (2010) The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer. Jpn J Clin Oncol 40(Suppl 1):i13–i18. doi:10.1093/jjco/hyq122

    Article  PubMed  Google Scholar 

  3. KCCR (2009) Annual report of the central cancer registry in Korea. Central Cancer Registry Center, Korea Central Cancer Registry (KCCR)

  4. Yoo KY, Kim Y, Park SK, Kang D (2006) Lifestyle, genetic susceptibility and future trends of breast cancer in Korea. APJCP 7(4):679–682

    PubMed  Google Scholar 

  5. Lim S, Shin H, Song J, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK (2011) Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care 34(6):1323–1328. doi:10.2337/dc10-2109

    Google Scholar 

  6. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591. doi:10.1038/nrc1408

    Article  PubMed  CAS  Google Scholar 

  7. Song YM, Sung J, Ha M (2008) Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 26(20):3395–3402. doi:10.1200/JCO.2007.15.7867

    Article  PubMed  Google Scholar 

  8. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, Ohmori K, Nishino Y, Tsuji I (2005) Obesity and risk of cancer in Japan. Int J Cancer 113(1):148–157. doi:10.1002/ijc.20529

    Article  PubMed  CAS  Google Scholar 

  9. Weiderpass E, Braaten T, Magnusson C, Kumle M, Vainio H, Lund E, Adami HO (2004) A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13(7):1121–1127

    PubMed  Google Scholar 

  10. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA (2007) Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 14(3):669–677. doi:10.1677/ERC-06-0089

    Article  PubMed  CAS  Google Scholar 

  11. Friedenreich CM (2001) Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10(1):15–32

    Article  PubMed  CAS  Google Scholar 

  12. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabetic Med J Br Diabetic Assoc 23(5):469–480. doi:10.1111/j.1464-5491.2006.01858.x

    Google Scholar 

  13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404

    Article  PubMed  Google Scholar 

  14. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96(15):1152–1160. doi:10.1093/jnci/djh216

    Article  PubMed  CAS  Google Scholar 

  15. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C (1999) Hypertension and hormone-related neoplasms in women. Hypertension 34(2):320–325

    Article  PubMed  CAS  Google Scholar 

  16. Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86(3):s823–s835

    PubMed  Google Scholar 

  17. Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML, Thomson CA, Rohan TE (2009) A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 18(7):2046–2053. doi:10.1158/1055-9965.EPI-09-0235

    Article  PubMed  CAS  Google Scholar 

  18. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V (2010) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case–control study. Nutr Metab Cardiovasc Dis 20(1):41–48. doi:10.1016/j.numecd.2009.02.006

    Article  PubMed  CAS  Google Scholar 

  19. Russo A, Autelitano M, Bisanti L (2008) Metabolic syndrome and cancer risk. Eur J Cancer 44(2):293–297. doi:10.1016/j.ejca.2007.11.005

    Article  PubMed  Google Scholar 

  20. Chen TH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, Tung TH, Huang CC, Chan CC, Shiu MN, Yeh YP, Liou HH, Liao CS, Lai HC, Chiang CP, Peng HL, Tseng CD, Yen MS, Hsu WC, Chen CH (2004) Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 100(8):1734–1743. doi:10.1002/cncr.20171

    Article  PubMed  Google Scholar 

  21. Inoue M, Noda M, Kurahashi N, Iwasaki M, Sasazuki S, Iso H, Tsugane S (2009) Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 18(3):240–247. doi:10.1097/CEJ.0b013e3283240460

    Article  PubMed  Google Scholar 

  22. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Haggstrom C, Stattin P, Engeland A (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 19(7):1737–1745. doi:10.1158/1055-9965.EPI-10-0230

    Article  PubMed  Google Scholar 

  23. Osaki Y, Taniguchi S, Tahara A, Okamoto M, Kishimoto T (2012) Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol 36(2):141–147. doi:10.1016/j.canep.2011.03.007

    Article  PubMed  Google Scholar 

  24. Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M (2009) Rationale for redefining obesity in Asians. Ann Acad Med Singapore 38(1):66–69

    PubMed  Google Scholar 

  25. Kim Y, Park SK, Han W, Kim DH, Hong YC, Ha EH, Ahn SH, Noh DY, Kang D, Yoo KY (2009) Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiol Biomarkers Prev 18(2):508–515. doi:10.1158/1055-9965.EPI-08-0133

    Article  PubMed  CAS  Google Scholar 

  26. Ha M, Sung J, Song YM (2009) Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. CCC 20(7):1055–1060. doi:10.1007/s10552-009-9301-7

    PubMed  Google Scholar 

  27. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11(11):1361–1368

    PubMed  CAS  Google Scholar 

  28. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49(5):945–952. doi:10.1007/s00125-006-0207-6

    Article  PubMed  CAS  Google Scholar 

  29. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2):194–202. doi:10.1001/jama.293.2.194

    Article  PubMed  CAS  Google Scholar 

  30. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156(4):349–352

    Article  PubMed  Google Scholar 

  31. Oda E, Kawai R (2010) Comparison among body mass index (BMI), waist circumference (WC), and percent body fat (%BF) as anthropometric markers for the clustering of metabolic risk factors in Japanese. Intern Med 49(15):1477–1482

    Article  PubMed  Google Scholar 

  32. Abbasi F, Malhotra D, Mathur A, Reaven GM, Molina CR (2012) Body mass index and waist circumference associate to a comparable degree with insulin resistance and related metabolic abnormalities in South Asian women and men. Diabetes Vasc Dis Res Off J Int Soc Diabetes Vasc Dis 9(4):296–300. doi:10.1177/1479164111433578

    Article  Google Scholar 

  33. Korean Ministry of Health and Welfare (2008) National Health and Nutrition Examination Survey Report 2007. Ministry of Health and Welfare, Seoul

Download references

Acknowledgments

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20120004255).

Conflict of interest

The authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yun-Mi Song.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 78 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Noh, HM., Song, YM., Park, JH. et al. Metabolic factors and breast cancer risk in Korean women. Cancer Causes Control 24, 1061–1068 (2013). https://doi.org/10.1007/s10552-013-0183-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-013-0183-3

Keywords

Navigation